The Department of Veterans Affairs has been accused of being too bureaucratic to function, and nobody can seem to lead it for much longer than a few years. But the VA hasn’t always been struggling. So just when did things go so wrong for the VA? » Read More
By: Christina Farr
Krishna Yeshwant is a venture capitalist and doctor who has a crafty way to think through his health-tech investments. » Read More
A statement late Friday said the confirmed cases are in Mbandaka city, where a single case was confirmed earlier in the week. » Read More
By: Kellie Ell
Aimovig from Amgen and Novartis could become a $1 billion to $2 billion business in five years, say one Wall Street analyst. » Read More
Johnson and Johnson said it would stop mid-stage trials testing its experimental Alzheimer's drug after observing safety issues.
Major pharmaceutical companies have spent billions of dollars in an effort to patent their products and avoid generic copies of blockbuster medicines, but the FDA commissioner has vowed to end this, the New York Times reports.
A number of behavioral factors explain why it's so hard to ignore free food in the office, but you can do a few things to improve your chances of resisting.
As would-be parents push back parenthood, companies that provide baby products are feeling the pinch.
Bill Gates says President Trump twice asked him the difference between HPV and HIV.
Amgen won U.S. Food and Drug Administration approval on Thursday for the first drug to prevent migraine headaches in adults. The drug, Aimovig, which is given monthly by self-injection, will have a list price of $6,900 a year, or $575 a month.
The Trump administration should address the high cost of prescription drugs in trade negotiations, Mt. Sinai CEO Kenneth Davis says.
The harvest season for romaine lettuce, linked to the multi-state E. coli outbreak, is over, according to the FDA.
The U.N. body will convene an Emergency Committee meeting on Friday to consider the international risks.
The U.S. Food and Drug Administration approved the first nonopioid treatment to ease withdrawal from quitting addictive opioids.
Venture capitalist and Palantir co-founder Joe Lonsdale is shifting his attention to health care.
New research on the high costs and complexity of health records comes as Apple is jumping into the market.
Sun Basket tells CNBC it has created recipes with the help of the American Diabetes Association to better assist diabetics manage their blood glucose levels without sacrificing on flavor.
In preparation for one of the most intense mosquito seasons, Florida officials will be tackling the little bloodsuckers using drones. US News & World Report has the story.
Tracking tweets and monitoring chat groups could shed light on the soaring popularity and use of the flash drive-shaped Juul e-cigarette, researchers say.
The Amazon, Berkshire and J.P. Morgan partnership to find grand health-care solutions remains leaderless.
Get the best of CNBC in your inbox